CORRESP 1 filename1.htm
CytoSorbents Corporation
305 College Road East
Princeton, New Jersey 08540
(732) 329-8885
September 27, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Benjamin Richie
| Re: |
| Registration Statement on Form S-3 |
| Filed July 26, 2024 |
| File No. 333-281062 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CytoSorbents Corporation hereby requests acceleration of the effective date of the above referenced registration statement so that such registration statement may become effective at 4:00 P.M. (Washington, D.C. time) on September 30, 2024, or as soon as practicable thereafter.
CytoSorbents Corporation
| By: |
/s/ Dr. Phillip P. Chan |
| Name: |
Dr. Phillip P. Chan |
| Title: |
Chief Executive Officer |
Field: Page; Sequence: 1; Options: Last
Field: /Page